scholarly journals ASSOCIATION OF DENGUE VIRUS TYPE-SPECIFIC IGG ON PLATELETS IS SPECIFIC FOR THE ACUTE PHASE IN AN IMPORTED JAPANESE PATIENT WITH SECONDARY DENGUE 2 VIRUS INFECTION

2003 ◽  
Vol 31 (4) ◽  
pp. 223-225 ◽  
Author(s):  
KAZUNORI OISHI ◽  
SHINGO INOUE ◽  
TSUYOSHI KURAMOTO ◽  
SHOZABURO ONIZUKA ◽  
MARIKO SAITO ◽  
...  
Cell Reports ◽  
2020 ◽  
Vol 31 (4) ◽  
pp. 107569 ◽  
Author(s):  
Daniela Michlmayr ◽  
Eun-Young Kim ◽  
Adeeb H. Rahman ◽  
Rohit Raghunathan ◽  
Seunghee Kim-Schulze ◽  
...  

Blood ◽  
2005 ◽  
Vol 106 (11) ◽  
pp. 5331-5331
Author(s):  
Myrna S. Figueroa ◽  
Luis A. Clavell

Abstract Dengue virus infections are a frequent cause of morbidity and mortality in certain endemic areas of the world but it has never been reported to occur in a bone marrow transplant patient. We describe a pediatric patient with ALL on her first bone marrow relapse undergoing allogeneic bone marrow transplant who developed sepsis and irreversible shock that on postmortem autopsy proved to be secondary to dengue virus infection Type 4. A 6 years old female with ALL underwent an allogeneic bone marrow transplant from her sibling (6/6 match) on Nov 10, 1994. She received TBI (1200 rads) and ARA-C (3gm/m2 per dose per 12 doses) as preparative regimen. She developed generalized skin erythema on day +5 followed by fever on day +6. The following days were characterized by continued fever spikes, severe mucositis, persistence of the erythematous skin rash (first degree burn like) and gross hematuria in spite of broad spectrum antibiotic coverage. Blood cultures were reported negative. She developed irreversible shock and finally died on day +11 post-transplant. At autopsy (Nov 22, 1994), Dengue virus type 4 was isolated from blood, ascitic fluid, liver and spleen by routine viral culture at San Juan C.D.C. Dengue Branch. Results were confirmed by polymerase chain reaction. Her donor also developed low grade fever the day after bone marrow donation. Further blood testing on donor (Dec 2, 1994) showed positive IgM antibodies against Dengue virus Type 4. The recipient viral cultures matches with donor acute titers for Dengue Type 4, suggesting infection through bone marrow transplant. Dengue virus infection may cause significant morbidity and mortality to blood and bone marrow recipients in endemic areas of the world.


2005 ◽  
Vol 134 (4) ◽  
pp. 820-825 ◽  
Author(s):  
A. SA-NGASANG ◽  
S. ANANTAPREECHA ◽  
A. A-NUEGOONPIPAT ◽  
S. CHANAMA ◽  
S. WIBULWATTANAKIJ ◽  
...  

IgM- and IgG-capture ELISAs are widely used as diagnostic tests for confirmation of dengue virus infection. The positive rate of anti-dengue IgM and IgG detection was examined in primary and secondary dengue virus infections in the setting of a provincial hospital using IgM- and IgG-capture ELISAs. Disease day 1 was defined as the day of onset of symptoms. In total, 232 plasma samples were collected from 106 confirmed dengue cases consisting of 12 primary and 94 secondary infections. In primary infection, anti-dengue IgM was detected in 4 out of 5 samples collected on disease day 5 and in all the 21 samples collected on disease day 6 or later. Specific IgG was detected in 2 out of 5 samples collected on day 12, and in 5 out of 6 samples collected on disease days 13–15, but was not detected in samples collected on disease day 10 or earlier. In secondary infection, IgM was not detected in the samples on disease days 2 and 3, but detected in 20 out of 79 samples collected on days 4–6, in 44 out of 65 on disease days 7–11 and in 40 out of 51 samples on disease days 12–14. In contrast, specific IgG was detected in 21 out of 60 samples on disease days 4 and 5, in 13 out of 19 on disease day 6, in 62 out of 65 on disease days 7–11 and in all the samples collected on disease day 12 or later. The result indicate that seroconversion rates of IgM and IgG are different between primary and secondary infections, and suggest that detection of specific IgM and IgG is necessary for determining dengue virus infection and for differentiating primary and secondary dengue infections.


2017 ◽  
Vol 5 (29) ◽  
Author(s):  
Alyssa T. Pyke ◽  
Bixing Huang ◽  
David Warrilow ◽  
Peter R. Moore ◽  
Jamie McMahon ◽  
...  

ABSTRACT In 2015, a female patient returning to Australia from Sabah, Malaysia, was diagnosed with a suspected sylvatic dengue virus type 2 (DENV-2) infection, becoming the second case of imported highly divergent dengue virus infection recorded in Australia. We describe here the complete genome sequencing of the DENV-2 strain isolated from this patient.


2013 ◽  
Vol 158 (6) ◽  
pp. 1209-1220 ◽  
Author(s):  
Tomoyuki Yoshida ◽  
Tsutomu Omatsu ◽  
Akatsuki Saito ◽  
Yuko Katakai ◽  
Yuki Iwasaki ◽  
...  

Author(s):  
Y. Mizuno ◽  
A. Kotaki ◽  
F. Harada ◽  
S. Tajima ◽  
I. Kurane ◽  
...  

2017 ◽  
Vol 22 (26) ◽  
Author(s):  
Yaniv Lustig ◽  
Dana Wolf ◽  
Ora Halutz ◽  
Eli Schwartz

Dengue virus infection was diagnosed in six Israeli travellers returning from the Seychelles in April 2017. Phylogenetic analysis identified identical sequences belonging to the Cosmopolitan genotype of dengue virus type 2 in all samples sequenced, thus providing evidence for a probable dengue type 2 outbreak in the Seychelles. This report further demonstrates the role of travellers as sentinels for arboviral infections, especially in countries with limited diagnostic capabilities.


Sign in / Sign up

Export Citation Format

Share Document